US equities |
TSLA $391.62 ▲+5.21% MU $903.70 ▲+2.98% META $630.56 ▼-1.88% NVDA $216.00 ▲+2.39% AAPL $343.91 ▼-1.10% SPCX $146.90 ▼-0.40% MSFT $532.60 ▲+1.54% AMD $531.28 ▲+2.80%
FinancialContent

Tilray Brands Inc (TSX:TLRY)

3.820 -0.120 (-3.05%)
Delayed Quote Updated: 4:00 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands Inc

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Tilray Acquires Majority Position in Amended MedMen Convertible Notes
From Tilray, Inc.
Via Business Wire
News headline image
Tilray Launches New Medical Cannabis Edibles in Canada
From Tilray, Inc.
Via Business Wire
News headline image
Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021
From Tilray, Inc.
Via Business Wire
Global Cannabidiol Market Size Expected to Reach $2.8 Billion by 2028 with a CAGR of 21%
Via FinancialNewsMedia
Topics Cannabis
News headline image
Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results
From Tilray, Inc.
Via Business Wire
News headline image
CIBC Continues To Downgrade The Canadian Cannabis Sector ↗
One day after CIBC slashed its price target on Tilray, Inc. (TSX: TLRY) (Nasdaq: TLRY), the broker-dealer lowered its price target on Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC) to C$30 from... 
Via Talk Markets
Topics Cannabis
CBD Product Sales Could Reach Nearly $17 Billion Dollars In The U.S. Alone By 2025
Via FinancialNewsMedia
Topics Cannabis
News headline image
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Tilray Shareholders Vote “FOR” All Proposals at Tilray’s Upcoming Special Meeting
From Tilray, Inc.
Via Business Wire
News headline image
Tilray to Announce Fourth Quarter and Fiscal 2021 Financial Results on July 28, 2021
From Tilray, Inc.
Via Business Wire
CBD-Infused Beverages Market Is Expected to Exceed $14 Billion by End of 2026
Via FinancialNewsMedia
Topics Cannabis Derivatives
News headline image
Leading Independent Proxy Advisory Firm ISS Recommends Tilray Shareholders Vote “FOR” All Proposals at Tilray’s Upcoming Special Meeting
From Tilray, Inc.
Via Business Wire
News headline image
Tilray’s Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of Medical Cannabis Grown in Germany
From Tilray, Inc.
Via Business Wire
News headline image
Tilray Introduces Its First Cross-brand Product Collaboration and Launches Canadian Craft Cannabis Brand, Broken Coast, in the U.S.
From Tilray, Inc.
Via Business Wire
News headline image
Tilray Asks Stockholders to Support Key Initiatives to Drive Strategic Growth and Strengthen Stockholder Rights
From Tilray, Inc.
Via Business Wire
Advancing Medical R&D for Cannabinoid Medicinal Uses Identifying Growing Number of Health Benefits
Via FinancialNewsMedia
Topics Cannabis
News headline image
Tilray Announces Launch of New Medical Cannabis Brand, Symbios
From Tilray, Inc.
Via Business Wire
Global Cannabidiol (CBD) Market Size Expected to Reach $55 Billion In 2028
Via FinancialNewsMedia
Topics Cannabis
News headline image
Tilray to Webcast Fireside Chats From Two Investor Conferences in June
From Tilray, Inc.
Via Business Wire
News headline image
Tilray to Participate in BMO Capital Markets Investor Conference
From Tilray, Inc.
Via Business Wire
Cannabis Stock Movers: Top Advancers and Decliners on Wednesday 5/5/21
Via FinancialNewsMedia
Topics Cannabis
News headline image
Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”
From Tilray, Inc.
Via Business Wire
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >